News

LCN Researcher Awarded President’s Special Award for Pandemic Service

LCN Professor Harris Makatsoris, has been awarded for his work on the production of synthetic RNA vaccines against the Coronavirus pathogen with advanced manufacturing intensification technology.

Granted for exceptional engineering achievements in tackling the challenges of the COVID-19 pandemic, this award from the Royal Academy of Engineering has been made to 19 winners across the UK’s engineering community.

Harris’ research has led to the development of a ‘factory-in-a-box’ that allows the rapid manufacture of synthetic RNA vaccines against the SARS-CoV-2 virus, thus minimising the space required for high-volume vaccine production.

Harris described the way his research will impact COVID-19 efforts:

This research adds a new tool in the manufacturing toolbox for vaccines and other RNA based therapeutics. A conventional vaccine manufacturing plant requires several months and a significant multi-million pound investment to be built. There is therefore an urgent need for a dramatic and rapid increase in manufacturing capacity and this can be addressed with new thinking and technology that pushes convention and current boundaries. We work precisely to achieve that with research that combines flow technologies with computer control, delivers compact, reproducible manufacturing environments to make these therapeutics reliably and continuously, and ultimately at the point-of-use. The result is manufacturing capability that can scale rapidly to meet the needs of the population, reducing dependency on overseas supply and at a small fraction of the investment required for a typical biopharmaceutical plant.

Harris is a Professor of Sustainable Manufacturing Systems in the Department of Engineering at King’s College London. His research interests include a focus on Artificial Intelligence for process automation, Circular Manufacturing Systems enabled by bioprocessing, and flow technologies for vaccines manufacturing

Watch Harris’ Spotlight on COVID interview to find out more about his’ ‘factory-in-a-box’ solution to vaccine manufacturing.

Professor Anatoly Zayats, co-director of the LCN said:

We are extremely proud for Harris and his team. LCN research is very agile and capable to respond very quickly to most tough challenges on a short notice. Very many thanks to Harris and all the LCN researchers for helping to beat the pandemic.

Part of this article first appeared on the King’s College London webpage

People: Harris Makatsoris

Professor-Harris-Makatsoris

More news

The LCN captivates crowds at The Great Exhibition Road Festival!

The LCN captivates crowds at The Great Exhibition Road Festival!

The LCN featured at the Great Exhibition Road Festival over the weekend of Saturday 6 and Sunday 7 June. Thousands of visitors came to ... Find out more

Professor Neil Alford elected as a Fellow of Royal Society

Professor Neil Alford elected as a Fellow of Royal Society

Professor Neil Alford has been elected a Fellow of the Royal Society! This is a huge honour and a well-deserved recognition of ... Find out more

Nanoneedle Technology Corrects Genetic Mutation in Rare Skin Disease

Nanoneedle Technology Corrects Genetic Mutation in Rare Skin Disease

LCN Researchers from the Faculty of Dentistry, Oral & Craniofacial Sciences at King’s College London have developed a novel ... Find out more

Equipment & Facilities

EDUCATION

Training

Loading...
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.